Ruminant Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Cattle, Sheep & Goats), By Vaccine Type, By Indication, By Route Of Administration, By Region, And Segment Forecasts, 2025 - 2030

Ruminant Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Cattle, Sheep & Goats), By Vaccine Type, By Indication, By Route Of Administration, By Region, And Segment Forecasts, 2025 - 2030


Ruminant Vaccines Market Growth & Trends

The global ruminant vaccines market size is estimated to reach USD 7.02 billion by 2030, expanding at a CAGR of 7.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the increasing demand for animal protein, the prevalence of infectious diseases in ruminants, the rising livestock trade, and R&D advancements. In December 2022, Virbac, a key market player, expanded its capabilities with the inauguration of a new R&D center in Taiwan, in response to the growing demand for veterinary vaccines. This has enabled the company to develop innovative solutions and immune stimulants and/or enhance existing products on a domestic, regional, and global level.

The COVID-19 pandemic notably impacted the market for ruminant vaccines. This included disruptions in the supply chain, reduced access to veterinary services, impact on trade and exports, and economic constraints on farmers. For example, in 2020, Indian Immunologicals Ltd reported decreased trade, exports, and institutional businesses due to the pandemic. Despite this, the company continued to be the largest supplier of FMD vaccines in India. Furthermore, the economic slowdown of 2022 also significantly affected the market. Merck & Co., Inc. for instance, reported that livestock product sales were practically flat in 2022. This was attributed to the unfavorable impact of foreign exchange.

Support from governments, regulatory authorities, and animal health organizations drives the adoption of ruminant vaccines. All these institutions worldwide have recognized the importance of preventing and controlling animal diseases. They have implemented various initiatives and regulations to promote the use of vaccines in the ruminant sector. These initiatives include awareness campaigns, vaccination programs, and subsidies or incentives for farmers to vaccinate their animals. For instance, the World Organization for Animal Health manages vaccine banks to ensure the procurement of high-quality vaccines, facilitate economies of scale, and contribute to harmonizing global and regional control programs. As of January 2023, the organization manages 2 active vaccine banks focusing on peste des petits ruminants (PPR) and rabies.

Ruminant Vaccines Market Report Highlights
  • The cattle segment dominated the market, based on animal type, in 2024. The sheep & goats segment is projected to expand at the highest CAGR of 10.0% over the projection period
  • By vaccine type, the modified/ attenuated live vaccines segment contributed to the largest share of over 51.7% in 2024. The other vaccines segment, on the other hand, is anticipated to grow the fastest at a rate of 10.33% in the coming years
  • In 2024, based on indication, Bovine Respiratory Diseases (BRD) accounted for the highest share of around 34.3% of the market. The other indications segment is expected to grow at the fastest rate of over 10.1% during the forecast period
  • In terms of route of administration, the injectable segment dominated the market in 2024 and is expected to grow at a significant CAGR during the forecast period, while the intranasal segment is expected to grow at the fastest CAGR over the forecast period.
  • In 2024, North America accounted for the highest regional share of more than 37.74% of the market. Asia Pacific is anticipated to advance at a growth rate of about 9.0% owing to the thriving dairy and beef sector in key markets of the region
  • International trade of livestock and animal products has been increasing due to globalization and changing dietary preferences. However, the movement of animals across borders can also facilitate the spread of infectious diseases. To mitigate this risk, countries and trade organizations enforce strict import and export regulations, including vaccination requirements, driving the demand for ruminant vaccines to ensure compliance with trade regulations
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Animal Type
1.2.2. Vaccine Type
1.2.3. Indication
1.2.4. Route of Administration
1.2.5. Distribution Channel
1.2.6. Regional Scope
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Animal Type
2.2.2. Vaccine Type
2.2.3. Indication
2.2.4. Route of Administration
2.2.5. Distribution Channel
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Ruminant Vaccines Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increased demand for animal protein
3.2.1.2. Increasing prevalence of diseases
3.2.1.3. R&D/ Technological advancements
3.2.1.4. Initiatives by market participants
3.2.2. Market Restraint Analysis
3.2.2.1. Cost of vaccination
3.2.2.2. Limited access to ruminant vaccines
3.2.2.3. Lack of or limited knowledge
3.3. Ruminant Vaccines Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.3.2.7. Estimated Animal Population by key Species, key Country, 2018-2024
3.4. Regulatory Framework
3.5. Pricing Analysis
3.6. COVID-19 impact Analysis
Chapter 4. Ruminant Vaccines Market: Animal Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Ruminant Vaccines Market: Animal Type Movement Analysis
4.3. Ruminant Vaccines Market by Animal Type Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Cattle
4.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.6. Sheep & Goats
4.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5. Ruminant Vaccines Market: Vaccine Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Ruminant Vaccines Market: Vaccine Type Movement Analysis
5.3. Ruminant Vaccines Market by Vaccine Type Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Modified/ Attenuated Live
5.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6. Inactivated (Killed)
5.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7. Other Vaccines
5.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6. Ruminant Vaccines Market: Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Ruminant Vaccines Market: Indication Movement Analysis
6.3. Ruminant Vaccines Market by Indication Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. BVD Infection
6.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6. Bovine Respiratory Diseases (BRD)
6.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.7. Leptospirosis
6.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.8. Clostridial diseases
6.8.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.9. Diarrhea/ Scours
6.9.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.10. FMD
6.10.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.11. Other Indications
6.11.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7. Ruminant Vaccines Market: Route of Administration Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Ruminant Vaccines Market: Route of Administration Movement Analysis
7.3. Ruminant Vaccines Market by Route of Administration Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Injectable
7.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6. Intranasal
7.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 8. Ruminant Vaccines Market: Distribution Channel Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Ruminant Vaccines Market: Distribution Channel Movement Analysis
8.3. Ruminant Vaccines Market by Distribution Channel Outlook (USD Million)
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5. Retail
8.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6. E-Commerce
8.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.7. Hospital/Clinic Pharmacies
8.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 9. Ruminant Vaccines Market: Regional Estimates & Trend Analysis
9.1. Regional Dashboard
9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.3. North America
9.3.1. U.S.
9.3.1.1. Key country dynamics
9.3.1.2. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
9.3.2. Canada
9.3.2.1. Key country dynamics
9.3.2.2. Canada market estimates and forecasts 2018 - 2030 (USD Million)
9.3.3. Mexico
9.3.3.1. Key country dynamics
9.3.3.2. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. UK market estimates and forecasts 2018 - 2030 (USD Million)
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Germany market estimates and forecasts 2018 - 2030 (USD Million)
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. France market estimates and forecasts 2018 - 2030 (USD Million)
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Italy market estimates and forecasts 2018 - 2030 (USD Million)
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Spain market estimates and forecasts 2018 - 2030 (USD Million)
9.4.6. Sweden
9.4.6.1. Key country dynamics
9.4.6.2. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
9.4.7. Denmark
9.4.7.1. Key country dynamics
9.4.7.2. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
9.4.8. Norway
9.4.8.1. Key country dynamics
9.4.8.2. Norway market estimates and forecasts 2018 - 2030 (USD Million)
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Japan market estimates and forecasts 2018 - 2030 (USD Million)
9.5.2. China
9.5.2.1. Key country dynamics
9.5.2.2. China market estimates and forecasts 2018 - 2030 (USD Million)
9.5.3. India
9.5.3.1. Key country dynamics
9.5.3.2. India market estimates and forecasts 2018 - 2030 (USD Million)
9.5.4. Australia
9.5.4.1. Key country dynamics
9.5.4.2. Australia market estimates and forecasts 2018 - 2030 (USD Million)
9.5.5. South Korea
9.5.5.1. Key country dynamics
9.5.5.2. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
9.5.6. Thailand
9.5.6.1. Key country dynamics
9.5.6.2. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Key country dynamics
9.6.1.2. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
9.6.2. Argentina
9.6.2.1. Key country dynamics
9.6.2.2. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
9.7. MEA
9.7.1. South Africa
9.7.1.1. Key country dynamics
9.7.1.2. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Key country dynamics
9.7.2.2. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
9.7.3. UAE
9.7.3.1. Key country dynamics
9.7.3.2. UAE market estimates and forecasts 2018 - 2030 (USD Million)
9.7.4. Kuwait
9.7.4.1. Key country dynamics
9.7.4.2. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Recent Developments & Impact Analysis by Key Market Participants
10.3. Company Market Share Analysis, 2024
10.4. Company overview
10.4.1. Boehringer Ingelheim International GmbH
10.4.1.1. Company Overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Zoetis Services LLC
10.4.2.1. Company Overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Vaxxinova International BV
10.4.3.1. Company Overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Merck & Co., Inc.
10.4.4.1. Company Overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Bimeda Animal Health Ltd.
10.4.5.1. Company Overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Indian Immunologicals Ltd.
10.4.6.1. Company Overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Elanco
10.4.7.1. Company Overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. Virbac
10.4.8.1. Company Overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Ceva Santé Animale
10.4.9.1. Company Overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. CZ Vaccines S.A.U. (Zendal Group)
10.4.10.1. Company Overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings